medigraphic.com
ISSN 2078-7170 (Electronic)

2021, Number 4

<< Back Next >>

CorSalud 2021; 13 (4)

Atherogenic risk markers in pre-eclampsia

Suárez GJA, Gutiérrez MM

Language: Spanish
References: 21
Page: 408-413
PDF size: 228.84 Kb.


ABSTRACT

Introduction: The atherogenic role of pre-eclampsia with lipid profile changes are risk factors for atherosclerosis.
Objective: To assess atherogenic risk markers in women with pre-eclampsia.
Method: A cross-sectional descriptive study was carried out on 180 pregnant women who attended the pre-eclampsia/eclampsia. risk consultation at the Hospi-tal Gineco-Obstétrico Mariana Grajales between 2018-2019. The statistical analysis was performed in two stages, descriptive analysis: mean, median, mode and standard deviation and inferential analysis: Student's t-test (quantitative) and Chi-square (qualitative). The level of statistical significance was considered with a value of p<0.05.
Results: Women of childbearing age (29±6.8 years) with a family history of pre-eclampsia (39.6%), nulliparity (35.2%) and personal history of pre-eclampsia (29.6%) predominated, as well as obese pregnant women at the beginning of pregnancy (37.8%) and within this group, class I obesity. In the group of women who devel-oped pre-eclampsia, the levels of total cholesterol, triglycerides, glycemia, ab-dominal circumference, as well as the Castelli index and the triglycerides to high-density lipoprotein cholesterol ratio were significantly higher (p<0.0001).
Conclusions: Personal history of pre-eclampsia and obesity at the beginning of pregnancy, as well as high levels of glycemia, total cholesterol and triglycerides are indicators of atherogenic risk in women with pre-eclampsia.


REFERENCES

  1. López-Fuenzalida A, Illanes Aguilar L, Rodríguez Canales C, Contreras-Briceño F, Durán-Agüero S, Herrera-Valenzuela T, et al. Riesgo cardiometabó-lico y variación en el contenido graso/adiposo según el índice de masa corporal en niños de seis a nueve años. Nutr Hosp. 2019;36(2):379-86. [DOI]

  2. Caamaño Navarrete F, Alarcón Hormazábal M, Delgado Floody P. Niveles de obesidad, perfil metabólico, consumo de tabaco y presión arterial en jóvenes sedentarios. Nutr Hosp. 2015;32(5): 2000-6. [DOI]

  3. Navia Bueno MP, Yaksic Feraude N, Aguilar Mer-cado X, Farah Bravo J, Chambi E, Mollinedo Ro-cha E, et al. Factores de riesgo asociados a sín-drome metabólico en población habitante de 3600 y 4100 M. S. N. M. Rev Méd La Paz. 2015;21(2): 6-17.

  4. O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its asso-ciated pathologies. Obes Rev. 2015;16(1):1-12. [DOI]

  5. Fayfman M, Haw S. Diabetes in Racial and Ethnic Minorities in the United States: Individualizing Approaches to Diagnosis and Management. Curr Diabetes Rev. 2017;13(3):239-50. [DOI]

  6. Miguel Soca PE. Predictores de riesgo cardiome-tabólico. Rev Finlay [Internet]. 2015 [citado 16 Jun 2020];5(2):80-1. Disponible en: http://www. revfinlay. sld. cu/index. php/finlay/article/view/357/1400

  7. Castillo Hernández JL, Cuevas González MJ, Al-mar Galiana M, Romero Hernández EY. Síndrome metabólico, un problema de salud pública con di-ferentes definiciones y criterios. Rev Med UV. 2017;17(2):7-24.

  8. Armaza Céspedes AX, Chambi Cayo TT, Mamani Ortiz Y, Abasto González S, Luizaga López JM. Factores de riesgo nutricionales asociados al sín-drome metabólico en personal militar de la Fuer-za Aérea de Cochabamba, Bolivia. Gac Med Bol. 2016;39(1):20-5.

  9. Suárez González JA, Gutiérrez Machado M. Ca-racterización del riesgo cardiometabólico en mu-jeres de edad mediana con antecedentes de pre-eclampsia en la última década. CorSalud [Inter-net]. 2019 [citado 19 Jun 2020];11(1):30-6. Disponi-ble en: http://www. revcorsalud. sld. cu/index. php/cors/article/view/407/814

  10. American Diabetes Association. Management of diabetes in pregnancy. Sec. 12. In Standards of Medical Care in Diabetes–2015. Diabetes Care 2015;38(Supl. 1):S77–S79. [DOI]

  11. Fernández Alba JJ, Mesa Páez C, Vilar Sánchez Á, Soto Pazos E, González Macías MC, Serrano Ne-gro E, et al. Sobrepeso y obesidad como factores de riesgo de los estados hipertensivos del emba-razo: Estudio de cohortes retrospectivo. Nutr Hosp. 2018;35(4):874-80. [DOI]

  12. Johnsson IW, Haglund B, Ahlsson F, Gustafsson J. A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatr Obes. 2015;10(2):77-83. [DOI]

  13. Leaños-Miranda A, Nolasco-Leaños AG, Carrillo-Juárez RI, Molina-Pérez CJ, Sillas-Pardo LJ, Jimé-nez-Trejo LM, et al. Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia. Hypertension. 2020;76(3):892-900. [DOI]

  14. Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnos-tics and therapies. Nat Rev Nephrol. 2019;15(5): 275-89. [DOI]

  15. Tangerås LH, Austdal M, Skråstad RB, Salvesen KÅ, Austgulen R, Bathen TF, et al. Distinct first trimester cytokine profiles for gestational hyper-tension and preeclampsia. Arterioscler Thromb Vasc Biol. 2015;35(11):2478-85. [DOI]

  16. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285(12):1607-12. [DOI]

  17. Li X, Tan H, Huang X, Zhou S, Hu S, Wang X, et al. Similarities and differences between the risk fac-tors for gestational hypertension and preeclamp-sia: A population based cohort study in south Chi-na. Pregnancy Hypertens. 2016;6(1):66-71. [DOI]

  18. Valdés G. Preeclampsia y enfermedad cardiovas-cular: Un enfoque integral para detectar las fases subclínicas de complicaciones obstétricas y car-diovasculares. Rev Chil Cardiol. 2019;38(2):132-45. [DOI]

  19. Arabin B, Baschat AA. Pregnancy: An Underuti-lized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication. Front Pediatr [Internet]. 2017 [ci-tado 22 Jun 2020];5:69. Disponible en: https://doi. org/10. 3389/fped. 2017. 00069

  20. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive Dis-orders of Pregnancy: ISSHP Classification, Diag-nosis, and Management Recommendations for In-ternational Practice. Hypertension. 2018 Jul;72(1): 24-43. [DOI]

  21. Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circula-tion. 2019;139(8):1069-79. [DOI]




2020     |     www.medigraphic.com